Form 4: Vor Biopharma Inc. Executive Chakraborty Sells Shares to Cover Tax Obligations

Chief Scientific Officer Tirtha Chakraborty of Vor Biopharma Inc. sold 5,576 shares of common stock on September 3, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On September 3, 2024, Tirtha Chakraborty, the Chief Scientific Officer of Vor Biopharma Inc., disposed of 5,576 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations associated with the settlement of restricted stock units.
• The shares were sold at a price of $0.83 per share.
• Following the transaction, Chakraborty directly owns 171,796 shares of Vor Biopharma Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an executive's stock transaction for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. They can be driven by various factors, including personal financial planning, diversification, and tax obligations. Monitoring these transactions can provide insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The transaction is unlikely to have a significant impact on shareholders, employees, customers, suppliers, or creditors, as it is a routine sale of shares by an executive for tax purposes.

Key Dates